KLOW
KLOW is a four-peptide regenerative blend combining BPC-157, TB-500, KPV and GHK-CU for research focused on cellular repair, inflammation pathways, and tissue remodeling.
About KLOW
The KLOW blend brings together four well-studied peptides involved in inflammatory modulation, angiogenesis, cellular migration, and regenerative signaling. GHK-Cu is widely examined for its copper-mediated effects on gene expression and tissue remodeling; BPC-157 is researched for its influence on angiogenesis and gut-derived repair pathways; TB-500 (the active fragment of thymosin beta-4) is known for its role in actin regulation and cell mobility; and KPV, derived from α-MSH, is used for its potent interaction with inflammatory and immune pathways. Together, this combination allows researchers to explore synergistic effects across wound environments, cytokine signaling, and cellular restructuring models. The KLOW formulation is designed to support multi-pathway investigation into regeneration and inflammation.